Andere talen Gufic Biosciences Limited

Aandelen

GUFICBIO

INE742B01025

Vertraagde tijd Bombay S.E. Andere beurzen 12:00:48 29-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
320,5 ^INR	+2,67%		-7,18%	+1,58%

25/04	Gufic Biosciences Limited keurt hergroepering van verschillende comités goed	CI
04/04	Gufic Biosciences richt nieuwe volledige dochteronderneming op in Dubai	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Gufic Biosciences Limited Approves Reconstitution of Various Committees	25/04
Gufic Biosciences Forms New Wholly-Owned Arm in Dubai	04/04
Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai	03/04
Gufic Biosciences Limited Announces Demise of Shrirang Vaidya, Independent Director, Chairman of Audit Committee and Nomination and Remuneration Committee and Member of Risk Management Committee	02/04
Gufic Biosciences Secures Patent in India	15/03
Gufic Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Gufic Biosciences Gets New Patent in India	31/01
Gufic Biosciences Forms New Pharmaceutical Subsidiary	20/11
Gufic Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Lumosa Therapeutics Co., Ltd. Approves the Exclusive Licensing Agreement with Gufic Biosciences for LT1001, A Long-Acting Analgesic Injection	09/11
Gufic Biosciences Limited announced that it has received INR 999.9 million in funding from Motilal Oswal Financial Services Limited	11-10-23
Gufic Biosciences Limited Approves Final Dividend for the Financial Year Ended March 31, 2023	30-09-23
Gufic Biosciences Limited Approves Incorporation of Wholly Owned Subsidiary in Dubai, UAE	27-09-23
Gufic Biosciences Granted Patent for its Invention	15-09-23
Gufic Biosciences Gets Nod from Australian, Brazilian Regulators for Parecoxib Sodium Lyophilized Powder	12-09-23
Gufic Biosciences Limited Receives Approval of TGA, Australia and the National Health Surveillance Agency, Brazil for Parecoxib 40Mg Injection	11-09-23
Gufic Biosciences Limited Proposes Final Dividend for the Financial Year Ended March 31, 2023	06-09-23
Motilal Oswal Financial to Acquire 3% Stake in Gufic Biosciences for INR1 Billion	01-09-23
Gufic Biosciences Limited announced that it expects to receive INR 999.9 million in funding from Motilal Oswal Financial Services Limited	29-08-23
Gufic Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Gufic Biosciences Limited

Aandelen

GUFICBIO

INE742B01025

Andere talen

Filters